Painkiller manufacturer Reckitt Benckiser settled an Australian class action over its specific pain range last month

A $3.5m class action over Nurofen tablets that falsely claimed they could target specific types of pain could yield very small payments for individual claimants, if everyone who bought the products steps forward.

The painkiller’s manufacturer, Reckitt Benckiser, settled the class action over its specific pain range at the federal court in Sydney last month.

Continue reading…

Facebook Comments

This site uses Akismet to reduce spam. Learn how your comment data is processed.